Novartis may ratchet up its 2018 sales outlook, its finance chief said on Wednesday, despite halting planned U.S. drug price hikes amid pressure on the industry from President Donald Trump's administration over the high cost of medicines.
from Reuters: Health https://ift.tt/2uy2OKP
via IFTTT
0 comments: